InfuSystem Holdings, Inc. (NYSE:INFU) Shares Purchased by First Eagle Investment Management LLC

First Eagle Investment Management LLC boosted its position in InfuSystem Holdings, Inc. (NYSE:INFU) by 10.0% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 666,048 shares of the company’s stock after acquiring an additional 60,813 shares during the period. First Eagle Investment Management LLC owned about 3.13% of InfuSystem worth $4,549,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in InfuSystem by 1.7% in the first quarter. Vanguard Group Inc. now owns 1,083,730 shares of the company’s stock valued at $9,288,000 after purchasing an additional 18,432 shares during the last quarter. Wasatch Advisors LP increased its stake in shares of InfuSystem by 3.4% during the 4th quarter. Wasatch Advisors LP now owns 846,609 shares of the company’s stock valued at $8,923,000 after acquiring an additional 27,881 shares during the last quarter. Ranger Investment Management L.P. lifted its holdings in shares of InfuSystem by 4.7% during the 4th quarter. Ranger Investment Management L.P. now owns 689,842 shares of the company’s stock worth $7,271,000 after acquiring an additional 30,835 shares during the period. Bank of New York Mellon Corp boosted its position in shares of InfuSystem by 6.1% in the second quarter. Bank of New York Mellon Corp now owns 93,899 shares of the company’s stock worth $641,000 after acquiring an additional 5,391 shares during the last quarter. Finally, Kings Path Partners LLC purchased a new stake in InfuSystem in the second quarter valued at approximately $514,000. 71.13% of the stock is currently owned by institutional investors and hedge funds.

InfuSystem Price Performance

INFU stock opened at $6.50 on Friday. The stock has a market cap of $138.42 million, a price-to-earnings ratio of -650,000.00 and a beta of 1.46. The company has a quick ratio of 1.64, a current ratio of 2.07 and a debt-to-equity ratio of 0.64. InfuSystem Holdings, Inc. has a 12-month low of $5.74 and a 12-month high of $10.99.

InfuSystem (NYSE:INFU) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). The business had revenue of $33.70 million during the quarter. InfuSystem had a net margin of 0.28% and a return on equity of 0.70%.

Analyst Ratings Changes

Separately, StockNews.com raised shares of InfuSystem from a “buy” rating to a “strong-buy” rating in a research note on Friday.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.